Isolation of human genomic DNA for genetic analysis from premature neonates: a comparison between newborn dried blood spots, whole blood and umbilical cord tissue

BMC Genetics

Anikó Váradi¹  Elek Molnár⁴  Helena Kemp⁶  Maggie Williams²  Manal El-Bokle³  Karen Luyt⁵  Shavanthi Rajatileka¹ 

[1] Centre for Research in Biosciences, Department of Biological, Biomedical and Analytical Sciences, Faculty of Health and Applied Sciences, University of the West of England, Bristol BS16 1QY, UK;Bristol Genetics Laboratory, Pathology Sciences, Blood Sciences and Bristol Genetics, Southmead Hospital, Bristol BS10 5NB, UK;Southmead Hospital, Bristol BS10 5NB, UK;Centre for Synaptic Plasticity, School of Physiology and Pharmacology, University of Bristol, Medical Sciences Building, University Walk, Bristol BS8 1TD, UK;Neonatal Neuroscience, School of Clinical Sciences, University of Bristol, St Michael’s Hospital, Southwell Street, Bristol BS2 8EG, UK;Department of Chemical Pathology, Southmead Hospital, Bristol BS10 5NB, UK

关键词: Sample storage;    Pyrosequencing;    Genomic DNA;    Umbilical cord;    Newborn dried blood spots;    Single nucleotide polymorphism;    Premature newborns;   

Others  :  1086415
DOI  :  10.1186/1471-2156-14-105

 received in 2013-03-15, accepted in 2013-09-17,  发布年份 2013

【 摘 要 】

Background

Genotyping requires biological sample collection that must be reliable, convenient and acceptable for patients and clinicians. Finding the most optimal procedure of sample collection for premature neonates who have a very limited blood volume is a particular challenge. The aim of the current study was to evaluate the use of umbilical cord (UC) tissue and newborn dried blood spot (DBS)-extracted genomic DNA (gDNA) as an alternative to venous blood-derived gDNA from premature neonates for molecular genetic analysis.

All samples were obtained from premature newborn infants between 24-32 weeks of gestation. Paired blood and UC samples were collected from 31 study participants. gDNA was extracted from ethylenediaminetetraacetic acid (EDTA) anticoagulant-treated blood samples (~500 μl) and newborn DBSs (n = 723) using QIAamp DNA Micro kit (Qiagen Ltd., Crawley, UK); and from UC using Qiagen DNAeasy Blood and Tissue kit (Qiagen Ltd., Crawley, UK). gDNA was quantified and purity confirmed by measuring the A₂₆₀:A₂₈₀ ratio. PCR amplification and pyrosequencing was carried out to determine suitability of the gDNA for molecular genetic analysis. Minor allele frequency of two unrelated single nucleotide polymorphisms (SNPs) was calculated using the entire cohort.

Results

Both whole blood samples and UC tissue provided good quality and yield of gDNA, which was considerably less from newborn DBS. The gDNA purity was also reduced after 3 years of storage of the newborn DBS. PCR amplification of three unrelated genes resulted in clear products in all whole blood and UC samples and 86%-100% of newborn DBS. Genotyping using pyrosequencing showed 100% concordance in the paired UC and whole blood samples. Minor allele frequencies of the two SNPs indicated that no maternal gDNA contamination occurred in the genotyping of the UC samples.

Conclusions

gDNAs from all three sources are suitable for standard PCR and pyrosequencing assays. Given that UC provide good quality and quantity gDNA with 100% concordance in the genetic analysis with whole blood, it can replace blood sampling from premature infants. This is likely to reduce the stress and potential side effects associated with invasive sample collection and thus, greatly facilitate participant recruitment for genetic studies.

【 授权许可】

   
2013 Rajatileka et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Parker SP, Cubit WD: The use of dried blood spot samples in epidemiological studies. J Clin Pathol 1999, 52:633-639.
• [2]Steinberg K, Beck J, Nickerson D, Garcia-Closas M, Gallagher M, Caggana M, Reid Y, Cosentino M, Ji J, Johnson D, Hayes RB, Earley M, Lorey F, Hannon H, Khoury MJ, Sampson E: DNA banking for epidemiologic studies: a review of current practices. Epidemiol 2002, 13:246-254.
• [3]Holland NT, Smith MT, Eskenazi B, Bastaki M: Biological sample collection and processing for molecular epidemiological studies. Mutat Res/Rev Mutat Res 2003, 543:217-234.
• [4]Beckett SM, Laughton SJ, Pozza LD, McCowage GB, Marshall G, Cohn RJ, Milne E, Ashton LJ: Buccal swabs and treated cards: methodological considerations for molecular epidemiologic studies examining pediatric populations. Am J Epidemiol 2008, 167:1260-1267.
• [5]Usher R, Shepard M, Lind J: The blood of the newborn infant and placental transfusion. Acta Paediatr 1963, 52:497-512.
• [6]Bauer K, Linderkamp O, Versmold HT: Systolic blood pressure and blood volume in preterm infants. Arch Dis Child 1993, 69:521-522.
• [7]Aladangady N, Leung T, Costeloe K, Delpy D: Measuring circulating blood volume in newborn infants using pulse dye densitometry and indocyanine green. Paediatr Anaesth 2008, 18:865-871.
• [8]Tyson JE, Parikh NA, Langer J, Green C, Higgins RD: Intensive care for extreme prematurity: moving beyond gestational age. N Engl J Med 2008, 358:1672-1681.
• [9]Edwards JR, Ulrich PP, Weintrub PS, Cowan MJ, Levy JA, Wara DW, Vyas GN: Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. J Pediatr 1989, 115:200-203.
• [10]McCabe ER: Utility of PCR for DNA analysis from dried blood spots on filter paper blotters. Genome Res 1991, 1:99-106.
• [11]Cassol S, Salas T, Gill MJ, Montpetit M, Rudnik J, Sy CT, O’Shaughnessy MV: Stability of dried blood spot specimens for detection of human immunodeficiency virus DNA by polymerase chain reaction. J Clin Microbiol 1992, 30:3039-3042.
• [12]Harding D, Dhamrait S, Marlow N, Whitelaw A, Gupta S, Humphries S, Montgomery H: Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants. J Pediatr 2003, 143:746-749.
• [13]Malikova J, Votava F, Vrzalova Z, Lebl J, Cinek O: Genetic analysis of the CYP21A2 gene in neonatal dried blood spots from children with transiently elevated 17-hydroxyprogesterone. Clin Endocrinol 2012, 77:187-194.
• [14]Mei JV, Alexander JR, Adam BW, Hannon WH: Use of filter paperfor the collection and analysis of human whole blood specimens. J Nutr 2001, 131:1631S-1636S.
• [15]Rubin EM, Andrews KA, Kan YW: Newborn screening by DNA analysis of dried blood spots. Hum Genet 1989, 82:134-136.
• [16]Green A: Neonatal screening: current trends and quality control in the United Kingdom. Rinsho Byori 1998, 46:211-216.
• [17]Aoki K: Newborn screening in Japan. Southeast Asian J Trop Med Public Health 2003, 34(Suppl 3):80.
• [18]Olney RS, Moore CA, Ojodu JA, Lindegren ML, Hannon WH: Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr 2006, 148:618-622.
• [19]Hannelius U, Lindgren CM, Melen E, Malmberg A, Von Dobeln U, Kere J: Phenylketonuria screening registry as a resource for population genetic studies. J Med Genet 2005, 42:e60.
• [20]Rabe H, Wacker A, Hulskamp G, Homig-Franz I, Jorch G: Late cord clamping benefits extrauterine adaptation. Pediatr Res 1998, 44:454.
• [21]Rabe H, Reynolds G, Diaz-Rossello J: Early versus delayed umbilical cord clamping in preterm infants. Cochrane Database Syst Rev 2004, 4:CD003248.
• [22]Mercer JS, Vohr BR, McGrath MM, Padbury JF, Wallach M, Oh W: Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics 2006, 117:1235-1242.
• [23]Armson BA: Umbilical cord blood banking: implications for perinatal care providers. J Obstet Gynaecol Can 2005, 27:263-290.
• [24]Tong CK, Vellasamy S, Tan BC, Abdullah M, Vidyadaran S, Seow HF, Ramasamy R: Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell Biol Int 2011, 35:221-226.
• [25]Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C, Rodford J, Slater-Jefferies JL, Garratt E, Crozier SR, Emerald BS, Gale CR, Inskip HM, Cooper C, Hanson MA: Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes 2011, 60:1528-1534.
• [26]Anttila V, Stefansson H, Kallela M, Todt U, Terwindt GM, Calafato MS, Nyholt DR, Dimas AS, Freilinger T, Müller-Myhsok B, Artto V, Inouye M, Alakurtti K, Kaunisto MA, Hämäläinen E, de Vries B, Stam AH, Weller CM, Heinze A, Heinze-Kuhn K, Goebel I, Borck G, Göbel H, Steinberg S, Wolf C, Björnsson A, Gudmundsson G, Kirchmann M, Hauge A, Werge T, et al.: Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 2010, 42:869-873.
• [27]Mallolas J, Hurtado O, Castellanos M, Blanco M, Sobrino T, Serena J, Vivancos J, Castillo J, Lizasoain I, Moro MA, Dávalos A: A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med 2006, 203:711-717.
• [28]Santella RM: Approaches to DNA/RNA extraction and whole genome amplification. Cancer Epidemiol Biomarkers Prev 2006, 15:1585-1587.
• [29]Lehmann AS, Haas DM, McCormick CL, Skaar TC, Renbarger JL: Collection of human genomic DNA from neonates: a comparison between umbilical cord blood and buccal swabs. Am J Obstetrics Gynecol 2011, 204:362-372.
• [30]Halsall A, Ravetto P, Reyes Y, Thelwell N, Davidson A, Gaut R, Little S: The quality of DNA extracted from liquid or dried blood is not adversely affected by storage at 4°C for up to 24h. Int J Epidemiol 2008, 37:7-10.
• [31]Glasel JA: Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. Biotechniques 1995, 18:62-63.
• [32]Teare JM, Islam R, Flanagan R, Gallagher S, Davies MG, Grabau C: Measurement of nucleic acid concentrations. Biotechniques 1997, 22:1170-1117.
• [33]Sambrook J, Russell D: Molecular cloning: a laboratory manual. 3rd edition. Long Island, New York, USA: Cold Spring Harbor Laboratory Press; 2001.
• [34]Tataurov AV, You Y, Owczarzy R: Predicting ultraviolet spectrum of single stranded and double stranded deoxyribonucleic acids. Biophys Chem 2008, 133:66-70.
• [35]Hollegaard MV, Thorsen P, Norgaard-Pedersen B, Hougaard DM: Genotyping whole-genome-amplified DNA from 3-to 25-year-old neonatal dried blood spot samples with reference to fresh genomic DNA. Electrophoresis 2009, 30:2532-2535.
• [36]Hollegaard MV, Grove J, Grauholm J, Kreiner-Møller E, Bønnelykke K, Nørgaard M, Benfield TL, Nørgaard-Pedersen B, Mortensen PB, Mors O, Sørensen HT, Harboe ZB, Børglum AD, Demontis D, Ørntoft TF, Bisgaard H, Hougaard DM: Robustness of genome-wide scanning using archived dried blood spot samples as a DNA source. BMC Genet 2011, 12:58-64.
• [37]Chaisomchit S, Wichajarn R, Janejai N, Chareonsiriwatana W: Stability of genomic DNA in dried blood spots stored on filter paper. Southeast Asian J Tropical Med Public Health 2005, 36:270-273.
• [38]Bonnet J, Colotte M, Coudy D, Couallier V, Portier J, Morin B, Tuffet S: Chain and conformation stability of solid-state DNA: implications for room temperature storage. Nucleic Acids Res 2010, 38:1531-1546.
• [39]Anchordoquy TJ, Molina MC: Preservation of DNA. Cell Preserv Technol 2007, 5:180-188.
• [40]Makowski GS, Davis EL, Hopfer SM: The effect of storage on Guthrie cards: implications for deoxyribonucleic acid amplification. Ann Clin Lab Sci 1996, 26:458-469.
• [41]Rossmanith P, Röder B, Frühwirth K, Vogl C, Wagner M: Mechanisms of degradation of DNA standards for calibration function during storage. Appl Microbiol Biotechnol 2011, 89:407-417.